Shamila

Ditta

School of Medicine and Population Health

Research Assistant

s.ditta@sheffield.ac.uk
+44 114 222 0674

Barber House

Full contact details

Shamila Ditta

School of Medicine and Population Health

Barber House

Sheffield

S10 2HQ

Qualifications

BsC Speech and Language Sciences
MA Psychology and Education

Research interests

Qualitative Research
Diversity and Inclusion Research

Publications

Show: Featured publications All publications

Featured publications

This person does not have any publications available.

All publications

Journal articles

Bageta ML, López Balboa P, Bursnall M, Wilson I, Biggs K, Glover R, Hutchence K, Ditta S, Julious S, Poudel P , Nadeem M et al (2025) O04 Mission EB -mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: a randomised, double-blinded, placebo controlled, crossover trial. British Journal of Dermatology, 193(Supplement_3).
Bageta ML, Lopez-Balboa P, Bursnall M, Glover R, Hutchence K, Papaioannou D, Biggs K, Julious S, Wilson I, Tappenden P , Turton E et al (2025) Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with recessive dystrophic epidermolysis bullosa (MissionEB): a randomised, double-blind, placebo controlled, crossover, phase 3 trial with an internal phase 1 dose de-escalation phase. EClinicalMedicine. View this article in WRRO
Peace A, White DA, Hackney G, Bradburn M, Norman P, White S, Al-Chalabi A, Baird W, Beever D, Cade J , Coates E et al (2025) Randomised controlled trial with parallel process evaluation and health economic analysis to evaluate a nutritional management intervention, OptiCALS, for patients with amyotrophic lateral sclerosis: study protocol. BMJ Open, 15(5). View this article in WRRO
Chatters R, Dimairo M, Cooper C, Ditta S, Woodward J, Biggs K, Ogunleye D, Thistlethwaite F, Yap C & Rothman A (2024) Exploring the barriers to, and importance of, participant diversity in early-phase clinical trials: an interview-based qualitative study of professionals and patient and public representatives. BMJ Open, 14(3). View this article in WRRO
Biggs K, Ditta S, Bageta ML, Lopez-Balboa P, Glover R, Hutchence K, Papaioannou D, Julious S, Cooper C, Petrof G & Martinez AE () Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with Recessive Dystrophic Epidermolysis Bullosa (MissionEB): a qualitative sub study of a randomised, double-blind, placebo controlled, crossover, phase 3 trial. Orphanet Journal of Rare Diseases.